Amgen Inc
Change company Symbol lookup
Select an option...
AMGN Amgen Inc
BCE BCE Inc
CLX Clorox Co
RSG Republic Services Inc
BANX ArrowMark Financial Corp
VQS Viq Solutions Inc
SPY SPDR® S&P 500 ETF Trust
LPTV Loop Media Inc
NUVB Nuvation Bio Inc
ATTO Atento SA
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq), Evenity, LumaKras, Nplate, XGeva, and others. The Company focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.

Closing Price
$220.65
Day's Change
2.12 (0.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
221.85
Day's Low
217.19
Volume
(Heavy Day)
Volume:
3,884,681

10-day average volume:
2,691,990
3,884,681
  • Prev Close
    218.53
  • Today's Open
    219.58
  • Day's Range
    217.19-221.85
  • Avg Vol (10-day)
    2.7M
  • Last (time)
    3:59p ET 05/31/23
  • Last (size)
    240
  • 52-Wk Range
    214.48 - 296.67
    LowHigh
  • (11/08/22 - 05/26/23)
    2.88%
  • 20.7%
  • Market Cap
    117.9B
  • Shares Outstanding
    534.3M
  • 14.72
  • 14.85x
  • $8.52/3.90%
  • Ex-dividend Date
    05/17/23
  • Dividend Pay Date
    06/08/23
  • 0.6
  • 75.50
  • (% of float 05/15/23)
    1.42

Latest News

May 31, 2023
4:38 pm ET
MarketWatch
May 30, 2023
6:00 pm ET
PR Newswire
4:37 pm ET
MarketWatch
May 26, 2023
4:37 pm ET
MarketWatch
4:00 pm ET
PR Newswire
May 25, 2023
4:37 pm ET
MarketWatch
May 24, 2023
4:37 pm ET
MarketWatch
May 23, 2023
4:37 pm ET
MarketWatch
May 22, 2023
4:37 pm ET
MarketWatch
May 19, 2023
4:36 pm ET
MarketWatch
May 18, 2023
4:37 pm ET
MarketWatch
8:00 am ET
Globe Newswire
May 17, 2023
4:37 pm ET
MarketWatch
8:30 am ET
MarketWatch
May 16, 2023
4:37 pm ET
MarketWatch
11:31 am ET
PR Newswire
7:53 am ET
MarketWatch
7:08 am ET
MarketWatch
May 15, 2023
4:37 pm ET
MarketWatch
May 12, 2023
8:55 pm ET
Newsfile
7:16 pm ET
Globe Newswire
4:45 pm ET
Accesswire
4:37 pm ET
MarketWatch
3:44 pm ET
Newsfile
1:14 pm ET
Globe Newswire
10:26 am ET
Accesswire
10:01 am ET
Newsfile
5:45 am ET
PR Newswire
May 11, 2023
8:25 pm ET
Accesswire
7:46 pm ET
Newsfile
4:37 pm ET
MarketWatch
2:01 pm ET
Accesswire
1:33 pm ET
Newsfile
1:02 pm ET
Globe Newswire
12:48 pm ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.